Inventor
DILGER ANDREW K
US16 patents
Patents
16 patentsUS9453018B2Sep 27, 2016
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO13 citations92
US11053247B2Jul 6, 2021
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10336754B2Jul 2, 2019
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US9777001B2Oct 3, 2017
Macrocycles with aromatic P2′ groups as factor xia inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US12428421B2Sep 30, 2025
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10676477B2Jun 9, 2020
Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group
BRISTOL MYERS SQUIBB CO2 citations62
US10611776B2Apr 7, 2020
Spiroheptane salicylamides and related compounds as inhibitors of rock
BRISTOL MYERS SQUIBB CO1 citations61
US9951071B2Apr 24, 2018
Dihydropyridone P1 as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9409908B2Aug 9, 2016
Dihydropyridone p1 as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US10829501B2Nov 10, 2020
Spiroheptane salicylamides and related compounds as inhibitors of ROCK
BRISTOL MYERS SQUIBB CO0 citations50
US11008317B2May 18, 2021
Triazolopyridine inhibitors of myeloperoxidase and/or EPX
BRISTOL MYERS SQUIBB CO0 citations49
US9920075B2Mar 20, 2018
Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO1 citations48
US10287288B2May 14, 2019
Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties
BRISTOL MYERS SQUIBB CO0 citations41
US10273236B2Apr 30, 2019
Macrocyclic factor XIa inhibitors bearing heterocyclic groups
BRISTOL MYERS SQUIBB CO0 citations41
US10696674B2Jun 30, 2020
Spirolactams as inhibitors of ROCK
BRISTOL MYERS SQUIBB CO0 citations39
US10316035B2Jun 11, 2019
Triazolopyridine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO0 citations38